{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:47:15Z","timestamp":1766760435346,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ajem.2021.01.050","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T18:06:49Z","timestamp":1611684409000},"page":"77-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effectiveness of oritavancin for management of skin and soft tissue infections in the emergency department: A case series"],"prefix":"10.1016","volume":"43","author":[{"given":"Drew","family":"Dretske","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pulia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Moore","key":"10.1016\/j.ajem.2021.01.050_bb0005"},{"key":"10.1016\/j.ajem.2021.01.050_bb0010","unstructured":"P. Rui, K. Kang, and J. Ashman, \u201cNational Hospital Ambulatory Medical Care Survey: 2016 Emergency Department Summary Tables,\u201d 2016, [Online]. Available: https:\/\/www.cdc.gov\/nchs\/data\/nhamcs\/web_tables\/2016_ed_web_tables.pdf."},{"issue":"1","key":"10.1016\/j.ajem.2021.01.050_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5811\/westjem.2014.11.24133","article-title":"Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection","volume":"16","author":"Talan","year":"2015","journal-title":"West J Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.01.050_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clinthera.2015.11.014","article-title":"Economic impact of oritavancin for the treatment of acute bacterial skin and skin structure infections in the emergency department or observation setting: cost savings associated with avoidable hospitalizations","volume":"38","author":"Lodise","year":"2016","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.ajem.2021.01.050_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx008","article-title":"Increasing incidence, cost, and seasonality in patients hospitalized for cellulitis","volume":"4","author":"Peterson","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.ajem.2021.01.050_bb0030","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/cid\/civ311","article-title":"Oritavancin: a long-half-life lipoglycopeptide","volume":"61","author":"Saravolatz","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ajem.2021.01.050_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-016-0145-7","article-title":"Single-dose oritavancin compared to standard of care IV antibiotics for acute bacterial skin and skin structure infection in the outpatient setting: a retrospective real-world study","volume":"6","author":"Anastasio","year":"2017","journal-title":"Infect Dis Ther"},{"issue":"6","key":"10.1016\/j.ajem.2021.01.050_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy051","article-title":"A Real-world patient registry for oritavancin demonstrates efficacy and safety consistent with the phase 3 SOLO program","volume":"5","author":"Redell","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.ajem.2021.01.050_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40121-016-0119-9","article-title":"Single-dose oritavancin treatment of acute bacterial skin and skin structure infections: SOLO trial efficacy by Eron severity and management setting","volume":"5","author":"Deck","year":"2016","journal-title":"Infect Dis Ther"},{"issue":"2","key":"10.1016\/j.ajem.2021.01.050_bb0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajem.2019.158442","article-title":"Finding the niche: an interprofessional approach to defining oritavancin use criteria in the emergency department","volume":"38","author":"Baxa","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.01.050_bb0055","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ajem.2021.01.050_bb0060","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/cid\/cit318","article-title":"The \u2018epic\u2019 challenge of optimizing antimicrobial stewardship: the role of electronic medical records and technology","volume":"57","author":"Kullar","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ajem.2021.01.050_bb0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jemermed.2014.12.001","article-title":"Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital","volume":"48","author":"Pollack","year":"2015","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2021.01.050_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmi.2017.08.028","article-title":"Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis","volume":"24","author":"Agarwal","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2021.01.050_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40801-020-00192-w","article-title":"Clinical outcomes and economic impact of oritavancin for gram-positive infections: a Single Academic Medical Center Health System Experience","volume":"7","author":"Brownell","year":"2020","journal-title":"Drugs - Real World Outcomes"},{"issue":"7","key":"10.1016\/j.ajem.2021.01.050_bb0080","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ajem.2016.04.022","article-title":"Intravenous home infusion therapy instituted from a 24-hour clinical decision unit for patients with cellulitis","volume":"34","author":"Rentala","year":"2016","journal-title":"Am J Emerg Med"},{"issue":"1954","key":"10.1016\/j.ajem.2021.01.050_bb0085","article-title":"Lack of effect of oritavancin on warfarin pharmacokinetics in healthy adult subjects","volume":"3","author":"Bellibas","year":"2016","journal-title":"Open Forum Infect Dis"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572100053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572100053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:51:30Z","timestamp":1760025090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567572100053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":17,"alternative-id":["S073567572100053X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.01.050","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of oritavancin for management of skin and soft tissue infections in the emergency department: A case series","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.01.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}